Anterior Cutaneus Nerve and Distal Adductor Canal Block With USG for Total Knee Replacement Analgesia

Diskapi Teaching and Research Hospital

Status: Completed

Conditions: Knee Replacement Arthroplasty; Nerve Block; Pain Measurement

Treatments: Procedure: Distal adductor canala blockade and anterior cutaneus nerve blockade; Procedure: Adductor canal blockade

Study type: Interventional

Funder types: Other

Identifiers

NCT06201195

AEŞH-EK1-2023-556

Details and patient eligibility

About

This prospective clinical study was approved by the institutional ethics committee on September 27, 2023, and patient enrollment started in October 2023. the study aimed to evaluate the contribution of anterior femoral cutaneus nerve block to postoperative analgesia in total knee artroplasty.

The goal of this clinical trial is to compare analhesia effects of adductor canal blockade versus distal adductur canal blockade added anterior cutaneus nerve block in total knee arthroplasty.

The main questions it aims to answer are:

• question 1: does distal adductor canal blockade + anterior cutaneus nerve blokade superior analgesia then adductor canal block for undergoing TKP?
• question 2: does distal adductor canal blockade + anterior cutaneus nerve blokade decrease drain place pain on anterolateral face of knee?

Full description

Patients with American Society of Anesthesiologists classification status I-III scheduled for elective primary TKA using standard spinal anesthesia enroll for this trial. After surgery patient divided two groups: 1- adductor canal blockade 2- distal adductor canal blockade + anterior femoral cutaneus nerve blockade. At postoperative 3th, 10th, 24th hour VAS (visuel analouge scale), VAS move, incision plase pain-for top and down of patella, drain place pain, motor strenght for femoral nerve and siyatic nerve, first analjesic requirement time, opioid consumption, total analcesic requirement will be recorded.

Enrollment: 58 patients

Sex: All

Ages: 40 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Total knee artroplasty
• Spinal anesthesia
• ASA 1-3

Exclusion criteria

• Bupivacaine allergy
• Coagulopathy
• Infection on injection site

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

58 participants in 2 patient groups

Adductor canal block

Active Comparator group

Description:

Usg guidance adductor canal block with %0.25 Bupivacaine 20 ml

Treatment:

Procedure: Adductor canal blockade

Distal adductor canal block with anterior cutaneus nerve block

Active Comparator group

Description:

Usg guidance distal adductor canal block (%0.25 Bupivacaine 20 ml) with anterior cutaneus nerve block (%0.25 Bupivacaine 10 ml)

Treatment:

Procedure: Distal adductor canala blockade and anterior cutaneus nerve blockade